MX2021001521A - Estrategias de cultivo celular para modular la glucosilacion de proteinas. - Google Patents

Estrategias de cultivo celular para modular la glucosilacion de proteinas.

Info

Publication number
MX2021001521A
MX2021001521A MX2021001521A MX2021001521A MX2021001521A MX 2021001521 A MX2021001521 A MX 2021001521A MX 2021001521 A MX2021001521 A MX 2021001521A MX 2021001521 A MX2021001521 A MX 2021001521A MX 2021001521 A MX2021001521 A MX 2021001521A
Authority
MX
Mexico
Prior art keywords
cell culture
strategies
protein glycosylation
modulating protein
culture strategies
Prior art date
Application number
MX2021001521A
Other languages
English (en)
Inventor
Robert David Kiss
Inn Huam Yuk
Patrick Daniel Ahyow
Dang Anh Thuy Nguyen
Melissa Siu- Lan Mun
Kristen Leigh Douglas
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MX2021001521A publication Critical patent/MX2021001521A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La materia objeto descrita en la presente se refiere a medios de cultivo celular y estrategias de cultivo celular para modular el patrón de glucosilación, por ejemplo, el patrón de fucosilación y/o galactosilación, de una glucoproteína de interés, por ejemplo, un anticuerpo, así como a composiciones de glucoproteínas y de cultivo celular preparadas mediante el uso de tales medios y/o estrategias.
MX2021001521A 2018-08-10 2019-08-09 Estrategias de cultivo celular para modular la glucosilacion de proteinas. MX2021001521A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862717751P 2018-08-10 2018-08-10
PCT/US2019/045900 WO2020033827A1 (en) 2018-08-10 2019-08-09 Cell culture strategies for modulating protein glycosylation

Publications (1)

Publication Number Publication Date
MX2021001521A true MX2021001521A (es) 2021-04-19

Family

ID=67902575

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021001521A MX2021001521A (es) 2018-08-10 2019-08-09 Estrategias de cultivo celular para modular la glucosilacion de proteinas.

Country Status (14)

Country Link
US (1) US20210238644A1 (es)
EP (1) EP3833688A1 (es)
JP (1) JP2021533760A (es)
KR (1) KR20210043618A (es)
CN (1) CN112752769A (es)
AR (1) AR114548A1 (es)
AU (1) AU2019319970A1 (es)
BR (1) BR112021002480A2 (es)
CA (1) CA3107038A1 (es)
IL (1) IL280553A (es)
MX (1) MX2021001521A (es)
SG (1) SG11202100756RA (es)
TW (1) TW202021985A (es)
WO (1) WO2020033827A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4352094A1 (en) 2021-06-07 2024-04-17 Amgen Inc. Using fucosidase to control afucosylation level of glycosylated proteins
KR20230051921A (ko) 2021-10-12 2023-04-19 프레스티지바이오로직스 주식회사 항체 집단의 제조 방법
CN115651953A (zh) * 2022-11-17 2023-01-31 康日百奥生物科技(苏州)有限公司 抗体药物、制备方法及细胞培养基

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
EP1400536A1 (en) 1991-06-14 2004-03-24 Genentech Inc. Method for making humanized antibodies
ATE375365T1 (de) 1998-04-02 2007-10-15 Genentech Inc Antikörper varianten und fragmente davon
US6194551B1 (en) 1998-04-02 2001-02-27 Genentech, Inc. Polypeptide variants
EP1737969B2 (en) * 2004-04-15 2018-09-12 GlycoFi, Inc. Production of galactosylated glycoproteins in lower eukaryotes
JP5058483B2 (ja) * 2005-09-14 2012-10-24 オリンパス株式会社 生体試料の長期間ないし連続的検出方法
KR20110139292A (ko) * 2009-04-20 2011-12-28 화이자 인코포레이티드 단백질 글리코실화의 제어 및 그와 관련된 조성물 및 방법
US20110053223A1 (en) * 2009-08-14 2011-03-03 Robert Bayer Cell culture methods to make antibodies with enhanced adcc function
EP2511293A1 (en) * 2011-04-13 2012-10-17 LEK Pharmaceuticals d.d. A method for controlling the main complex N-glycan structures and the acidic variants and variability in bioprocesses producing recombinant proteins
WO2012149197A2 (en) * 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US9493744B2 (en) 2012-06-20 2016-11-15 Genentech, Inc. Methods for viral inactivation and other adventitious agents
WO2014170866A2 (en) * 2013-04-18 2014-10-23 Dr. Reddy's Laboratories Limited Process of obtaining glycoprotein composition with increased galactosylation content
MX2016001042A (es) * 2013-07-23 2017-01-05 Biocon Ltd Metodos para controlar los niveles de fucosilacion en proteinas.
HU231463B1 (hu) * 2015-08-04 2024-01-28 Richter Gedeon Nyrt. Módszer rekombináns proteinek galaktóz tartalmának növelésére

Also Published As

Publication number Publication date
EP3833688A1 (en) 2021-06-16
CN112752769A (zh) 2021-05-04
JP2021533760A (ja) 2021-12-09
AU2019319970A1 (en) 2021-03-11
TW202021985A (zh) 2020-06-16
CA3107038A1 (en) 2020-02-13
WO2020033827A1 (en) 2020-02-13
SG11202100756RA (en) 2021-02-25
IL280553A (en) 2021-03-25
AR114548A1 (es) 2020-09-16
KR20210043618A (ko) 2021-04-21
BR112021002480A2 (pt) 2021-07-27
US20210238644A1 (en) 2021-08-05

Similar Documents

Publication Publication Date Title
MX2021001521A (es) Estrategias de cultivo celular para modular la glucosilacion de proteinas.
MX2019003427A (es) Composiciones para cultivo celular y metodos para la produccion de polipeptidos.
MX2018005389A (es) Animales no humanos que tienen un gen 3 de activacion linfocitaria humanizado.
MX2022012042A (es) Composiciones de proteina anti-vegf y metodos para producir la misma.
MX2021008592A (es) Composiciones de trem y usos de las mismas.
EP3778901A4 (en) NEW PROMOTER AND PROCESS FOR THE PRODUCTION OF L-AMINO ACID USING THE PROMOTER
MX2019007995A (es) Novedoso polipeptido y procedimiento de produccion de imp mediante el uso del mismo.
MX2021008621A (es) Anticuerpos de inmunoglobulina a y metodos de produccion y uso.
EP4039796A4 (en) METHOD FOR PRODUCING COMPOSITION FOR CELL CULTURE, COMPOSITION FOR CELL CULTURE OBTAINED THEREBY, AND CELL CULTURE METHOD USING SAME
WO2020113141A3 (en) Cd86 variant immunomodulatory proteins and uses thereof
MX2021015301A (es) Métodos de cultivo celular y composiciones para la producción de anticuerpos.
MX2021015698A (es) Integración dirigida de configuraciones aleatorias de ácidos nucleicos.
WO2020205626A8 (en) Modulators of cell surface protein interactions and methods and compositions related to same
MX2018003445A (es) Expresion de proteinas que contienen fc.
WO2023010065A3 (en) Compositions and methods for anti-pacap antibodies
MX2022006316A (es) Composicion para la preparacion de alulosa y procedimiento para la preparacion de alulosa mediante el uso de la misma.
MX2020010028A (es) Actividad lactogenica modulada en celulas de mamifero.
EP3901253A4 (en) EMBRYONIC ERYTHROBLAST CONTAINING CELL POPULATION AND METHODS FOR THEIR PRODUCTION, CELL CULTURE COMPOSITION AND COMBINATION TESTING METHODS
UA74242U (en) Strain of somatic structures pleurotus ostreatus (jacq.: fr.) p. kumm p-208 - producer of exolactases